SCHEMBL14039079

SCHEMBL14039079

Nc1ccc(-n2c3ccccc3c3ccccc32)cc1-c1c(F)ccc(F)c1-c1cc(-n2c3ccccc3c3ccccc32)ccc1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ IDO1 P14902 2/20 0.35
▸ HDAC3 O15379 1/20 0.35
▸ EP300 Q09472 1/20 0.35
▸ KAT2B Q92831 1/20 0.35
▸ KAT8 Q9H7Z6 1/20 0.35
▸ NCOR2 Q9Y618 1/20 0.35
▸ HDAC4 P56524 1/20 0.32
▸ HSP90AA1 P07900 3/20 0.31
▸ HSP90AB1 P08238 3/20 0.31
▸ USP14 P54578 1/20 0.31
▸ MPI P34949 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ PABPC1 P11940 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ CSNK1A1 P48729 1/20 0.31
▸ CSNK1D P48730 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14039112 0.86 KDM4E (0.37) KDM4EL3MBTL1ATMIDO1HDAC3
SCHEMBL12811692 0.85 KDM4E (0.36) KDM4EL3MBTL1ATMIDO1HDAC3
SCHEMBL14039078 0.80 CTSB (0.42) KDM4EL3MBTL1IDO1HSP90AA1MEN1
SCHEMBL28446443 0.79 KDM4E (0.52) KDM4EL3MBTL1ATMIDO1HDAC4
SCHEMBL16521581 0.76 KDM4E (0.48) KDM4EL3MBTL1ATMIDO1HDAC3
SCHEMBL21524840 0.76 KDM4E (0.48) KDM4EL3MBTL1ATMIDO1HDAC3
SCHEMBL24777362 0.73 KDM4E (0.50) KDM4EL3MBTL1ATMHDAC4MPI
SCHEMBL18214486 0.70 KDM4E (0.54) KDM4EL3MBTL1ATMIDO1HDAC4
SCHEMBL30389001 0.70 KDM4E (0.42) KDM4EL3MBTL1ATMHDAC4HSP90AA1
SCHEMBL12754467 0.69 KDM4E (0.52) KDM4EL3MBTL1ATMHDAC4USP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 — — US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 — — US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 KDM4E 990/4885L3MBTL1 709/4885ATM 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback